Efficacy and safety of tofacitinib in patients with ulcerative colitis a prospective national multicenter cohort

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Ulcerative Colitis
  • Age: Between 18 - 1000 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Adult patients, age 18 years or older, with UC, who plan to start this therapy within the next 4 weeks. The start of the tofacitinib therapy must be initiated in the setting of standard of care therapy
    2. Anticipation that the patient will be followed by the participating center for the next 12 months
    3. Diagnosis of UC must be established on the basis of standard clinical, radiographic, endoscopic, and histologic criteria

You may not be eligible for this study if the following are true:

    1. Inability to provide informed consent
    2. Participants presenting for a one-time consultation

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.